| Market Cap | ₹36,697Cr |
| ROE | 18.75% |
| P/E Ratio(TTM) | 75.70 |
| EPS(TTM) | 8.63 |
| P/B Ratio | 13.33 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.15 |
| Book Value | 49.00 |
| Debt to Equity | 0.04 |
| Face Value | 2 |
| Founded | 2006 |
| NSE Symbol | ANTHEM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 77.70 | ||
| Onesource Specialty Pharma | NA (0.00%) | 641.63 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 20.71 | ||
| Panacea Biotec | NA (0.00%) | -293.47 |